SCYB.V - Scythian Biosciences Corp.

TSXV - TSXV Delayed Price. Currency in CAD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue-
Cost of Revenue-
Gross Profit-
Operating Expenses
Research Development-
Selling General and Administrative-
Non Recurring-
Total Operating Expenses2,996.259
Operating Income or Loss-2,996.259
Income from Continuing Operations
Total Other Income/Expenses Net-
Earnings Before Interest and Taxes-2,996.259
Interest Expense-49.278
Income Before Tax-
Income Tax Expense-
Minority Interest-
Net Income From Continuing Ops-
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect Of Accounting Changes-
Other Items-
Net Income
Net Income-2,976.064
Preferred Stock And Other Adjustments-
Net Income Applicable To Common Shares-